Haiti vs Papua New Guinea: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Haiti
39.0%
in 2025
Papua New Guinea
44.0%
in 2025
Haiti rank
160th
Papua New Guinea rank
159th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Haiti
- Papua New Guinea
How they compare
Papua New Guinea currently reports 44.0% against 39.0% in Haiti, a difference of 5.0%.
That makes Papua New Guinea's figure about 1.1 times Haiti's.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Papua New Guinea ahead.
Haiti ranks 160th and Papua New Guinea ranks 159th of 194 countries.
Across the 3 decades both report, Haiti averaged higher in 1 and Papua New Guinea in 1.
Head to head by decade
| Decade | Haiti | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 3.9% | 14.6% | 10.7% | Papua New Guinea |
| 2020s | 46.2% | 37.8% | 8.3% | Haiti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Haiti or Papua New Guinea?
- Papua New Guinea, at 44.0% against 39.0% in Haiti as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Haiti and Papua New Guinea?
- 5.0%, with Papua New Guinea ahead.
- How many years of comparable data are there for Haiti and Papua New Guinea?
- 18 years are reported by both, from 2008 to 2025.
- How do Haiti and Papua New Guinea rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Haiti ranks 160th and Papua New Guinea ranks 159th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.